NASDAQ:FCS Fairchild Semiconductor Intl (FCS) Stock Price, News & Analysis → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free FCS Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$19.86▼$19.8650-Day Range N/A52-Week Range$12.95▼$21.71VolumeN/AAverage Volume1.11 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Fairchild Semiconductor Intl alerts: Email Address Ad Behind the MarketsThe World's First "$20 Trillion Drug?"One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!Get the name of the stock here >>> About Fairchild Semiconductor Intl Stock (NASDAQ:FCS)Fairchild Semiconductor International, Inc. is focused on developing, manufacturing and selling power management solutions. The Company is engaged in power analog and discrete design, as well as packaging. It also makes non-power semiconductor and micro-electro-mechanical systems (MEMS)-based solutions. The Company's products are used in various end market applications, including industrial, home appliance, automotive, mobile, server and cloud computing, lighting and consumer electronics. It develops a range of power and signal path products for industrial, appliance, cloud computing and automotive applications. The Company's segments include Switching Power Solutions segment (SPS), the Analog Power and Signal Solutions segment (APSS), and Standard Products Group (SPG). It also invests in wafer fabrication and packaging technology to support the development of these products. The Company also has an eight-inch wafer fabrication site in Bucheon, Korea.Read More Ad Behind the MarketsThe World's First "$20 Trillion Drug?"One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!Get the name of the stock here >>> FCS Stock News HeadlinesApril 20, 2024 | morningstar.comVanguard International Semiconductor Corp 5347February 16, 2024 | morningstar.comSemiconductor Manufacturing International CorpApril 25, 2024 | Behind the Markets (Ad)The World's First "$20 Trillion Drug?"One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!September 27, 2023 | thestreet.comFairchild Semiconductor (FCS) Stock Down After Rejecting Latest Takeover BidMarch 27, 2023 | marketwatch.comVoltage Controlled Attenuators Market Size By 2031March 24, 2023 | wsj.comVanguard International Semiconductor Corp.February 25, 2023 | marketwatch.comSilicon Carbide (SiC) Semiconductor Market 2023 : Incredible Possibilities, Growth Analysis and Forecast To 2028January 24, 2023 | travel.usnews.comFairchild Tropical Botanic GardenSee More Headlines Receive FCS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Fairchild Semiconductor Intl and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/08/2016Today4/25/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustrySemiconductors Current SymbolNASDAQ:FCS CUSIP30372610 CIK1036960 Webwww.fairchildsemi.com Phone+1-408-8222000FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report FCS Stock Analysis - Frequently Asked Questions How were Fairchild Semiconductor Intl's earnings last quarter? Fairchild Semiconductor Intl Inc (NASDAQ:FCS) released its quarterly earnings data on Monday, August, 8th. The semiconductor company reported $0.13 earnings per share for the quarter, missing analysts' consensus estimates of $0.17 by $0.04. The semiconductor company earned $350 million during the quarter, compared to analysts' expectations of $338.70 million. What other stocks do shareholders of Fairchild Semiconductor Intl own? Based on aggregate information from My MarketBeat watchlists, some companies that other Fairchild Semiconductor Intl investors own include Onsemi (ON), Achillion Pharmaceuticals (ACHN), Citigroup (C), Ensco Rowan (ESV), Ford Motor (F), Home Depot (HD), J C Penney (JCP), Twitter (TWTR), VMware (VMW) and AcelRx Pharmaceuticals (ACRX). This page (NASDAQ:FCS) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fairchild Semiconductor Intl Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
